News for Zoetis Inc. (0M3Q.L)

Summary: Zoetis Inc. (ZTS) is positioned for a potential 35.1% return based on the current stock price and Wall Street forecasts.Analysts' average one-year pric

Stifel analyst Jonathan Block has revised his outlook for Zoetis (ZTS), reducing the price target from $180 to $165 while maintaining a Buy rating. This adjustm

Shares of Zoetis Inc (ZTS) fell 5.45% in mid-day trading on Apr 10. The stock reached an intraday low of $142.04, before recovering slightly to $145.18, dow

We recently published a list of 15 Stocks with Buy Ratings that Hedge Funds Love. In this article, we are going to take a look at where Zoetis Inc. (NYSE:ZTS) stands against other stocks with buy ratings that hedge funds love. The U.S. stock market has been in chaos ever since President Trump announced his […]

Zoetis operates in a growing animal healthcare market, benefiting from trends like pet humanization and medicalization. Read why ZTS stock is a Buy.

Zoetis Inc. (NYSE:ZTS) Barclays 27th Annual Global Healthcare March 11, 2025 10:30 AM ETCompany ParticipantsWetteny Joseph - Chief Financial...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going to take a look at where Zoetis Inc.

Zoetis Inc. (NYSE:ZTS) BofA Securities 2025 Animal Health Summit February 27, 2025 1:20 PM ETCompany ParticipantsWetteny Joseph - CFOConference Call...

Zoetis Inc (ZTS) has recently been in the spotlight, drawing interest from investors and financial analysts due to its robust financial stance. With shares curr

Robust product innovation and market leadership in veterinary diagnostics.Expansive global presence with a focus on enhancing veterinary practice efficiency.Ch

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for medicines in China.

Zoetis Inc (ZTS) announced that it has received a conditional license from the U.S. Department of Agriculture's Center for Veterinary Biologics for its Avian In

Shares of Zoetis Inc (ZTS) fell 3.25% in mid-day trading on Feb 14. The stock reached an intraday low of $157.50, before recovering slightly to $159.58, dow

Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance. Click here to find out why I rate ZTS stock a Buy.

Zoetis Inc. (NYSE:ZTS) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ETCompany ParticipantsSteve Frank - IRKristin Peck - CEOWetteny Joseph -...

The following slide deck was published by Zoetis Inc.

Zoetis Inc. (NYSE: ZTS) today reported its financial results for the fourth quarter and full year 2024 as well as provided full year guidance for 2025. The c

Revenue: $2.3 billion for Q4 2024, matching the estimated revenue of $2.3 billion, reflecting a 5% increase year-over-year.Earnings Per Share (EPS): Reported E

On Thursday, February 13, 2025, the stock market exhibited mixed performance as investors grappled with conflicting economic signals and geopolitical